Combating Illicit Xylazine Act
Sponsored By: Representative Panetta, Jimmy [D-CA-19]
Introduced
Summary
This bill would place xylazine on Schedule III of the Controlled Substances Act to curb illicit use and trafficking. It would also redefine who may possess xylazine legally, add the drug to federal tracking systems, and require sentencing guidance and periodic reports to Congress.
Show full summary
- Veterinarians and animal owners: The bill limits who counts as an "ultimate user" to people who receive xylazine from a veterinarian or a registered pharmacy. Possession is restricted to animals they own or care for and to government or wildlife program uses.
- Manufacturers and practitioners: Entities manufacturing xylazine at enactment would not have to install new capital security standards. Labeling rules are delayed for 1 year and practitioner registration, inventory, and recordkeeping requirements are delayed for 60 days to allow a transition.
- Law enforcement and courts: Federal ARCOS tracking would be expanded to include xylazine. The U.S. Sentencing Commission must review penalties and the Attorney General, DEA, and FDA must report to Congress at 18 months and again at 4 years on prevalence, trafficking, and related risks.
Your PRIA Score
Personalized for You
How does this bill affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
3 provisions identified: 3 benefits, 0 costs, 0 mixed.
Transition relief for xylazine makers and vets
If enacted, xylazine businesses would get transition relief. Existing makers would not have to install new Schedule III security systems. Labeling and shipping rules would start 1 year after enactment. Practitioner registration and record rules would start 60 days after enactment, and applicants could keep working while applications are pending. FDA and DEA would speed related paperwork for manufacturers.
Stronger federal controls on xylazine
If enacted, the government would treat xylazine as a Schedule III drug. DEA would add it to its national drug reporting system. Makers, distributors, and pharmacies would have to report xylazine shipments. The Sentencing Commission would review penalties for xylazine crimes. The bill would also define xylazine to include its salts and isomers.
Who can hold xylazine for animals
If enacted, a person who gets xylazine from a registered vet or pharmacy for an animal they own or care for would be the “ultimate user.” You would not need to register to possess that xylazine. This would also cover government animal‑control and wildlife programs, and businesses where animals are kept.
Sponsors & CoSponsors
Sponsor
Panetta, Jimmy [D-CA-19]
CA • D
Cosponsors
Pfluger
TX • R
Sponsored 2/12/2025
Bilirakis
FL • R
Sponsored 2/12/2025
Rep. Pappas, Chris [D-NH-1]
NH • D
Sponsored 2/12/2025
Fitzgerald
WI • R
Sponsored 2/12/2025
Rep. Ross, Deborah K. [D-NC-2]
NC • D
Sponsored 2/12/2025
Crenshaw
TX • R
Sponsored 2/12/2025
Rep. Harder, Josh [D-CA-9]
CA • D
Sponsored 2/12/2025
DelBene
WA • D
Sponsored 2/12/2025
Rep. Miller-Meeks, Mariannette [R-IA-1]
IA • R
Sponsored 2/12/2025
Rep. Pettersen, Brittany [D-CO-7]
CO • D
Sponsored 2/12/2025
Rep. Clarke, Yvette D. [D-NY-9]
NY • D
Sponsored 2/12/2025
Rep. Deluzio, Christopher R. [D-PA-17]
PA • D
Sponsored 2/12/2025
Rep. Magaziner, Seth [D-RI-2]
RI • D
Sponsored 2/12/2025
Rep. Bacon, Don [R-NE-2]
NE • R
Sponsored 2/12/2025
Obernolte
CA • R
Sponsored 2/12/2025
Costa
CA • D
Sponsored 2/12/2025
Balderson
OH • R
Sponsored 2/12/2025
Barragan
CA • D
Sponsored 2/12/2025
Ciscomani
AZ • R
Sponsored 2/12/2025
Rep. Carey, Mike [R-OH-15]
OH • R
Sponsored 2/12/2025
Rep. Bice, Stephanie I. [R-OK-5]
OK • R
Sponsored 2/12/2025
Craig
MN • D
Sponsored 2/12/2025
Norcross
NJ • D
Sponsored 2/12/2025
Rep. Fong, Vince [R-CA-20]
CA • R
Sponsored 2/12/2025
Rep. Tenney, Claudia [R-NY-24]
NY • R
Sponsored 2/12/2025
Rep. Fitzpatrick, Brian K. [R-PA-1]
PA • R
Sponsored 2/12/2025
Rep. Burchett, Tim [R-TN-2]
TN • R
Sponsored 2/12/2025
Rep. Dean, Madeleine [D-PA-4]
PA • D
Sponsored 2/12/2025
Cohen
TN • D
Sponsored 2/12/2025
Davis (NC)
NC • D
Sponsored 2/12/2025
Rep. Correa, J. Luis [D-CA-46]
CA • D
Sponsored 2/12/2025
Webster (FL)
FL • R
Sponsored 2/12/2025
Rep. Collins, Mike [R-GA-10]
GA • R
Sponsored 2/12/2025
Rep. Suozzi, Thomas R. [D-NY-3]
NY • D
Sponsored 2/12/2025
Rep. Harshbarger, Diana [R-TN-1]
TN • R
Sponsored 2/12/2025
Rep. Salinas, Andrea [D-OR-6]
OR • D
Sponsored 2/14/2025
Lee (FL)
FL • R
Sponsored 2/14/2025
Wittman
VA • R
Sponsored 2/14/2025
Rep. Mann, Tracey [R-KS-1]
KS • R
Sponsored 2/14/2025
Soto
FL • D
Sponsored 2/14/2025
Cherfilus-McCormick
FL • D
Sponsored 2/24/2025
Haridopolos
FL • R
Sponsored 2/24/2025
Sewell
AL • D
Sponsored 2/24/2025
Rep. Rulli, Michael A. [R-OH-6]
OH • R
Sponsored 2/24/2025
Rep. Finstad, Brad [R-MN-1]
MN • R
Sponsored 2/25/2025
Rep. Davids, Sharice [D-KS-3]
KS • D
Sponsored 2/25/2025
Rep. Yakym, Rudy [R-IN-2]
IN • R
Sponsored 2/25/2025
Rep. Self, Keith [R-TX-3]
TX • R
Sponsored 3/3/2025
Rep. Harris, Andy [R-MD-1]
MD • R
Sponsored 3/3/2025
Rep. Calvert, Ken [R-CA-41]
CA • R
Sponsored 3/3/2025
Johnson (SD)
SD • R
Sponsored 3/3/2025
Rep. Kelly, Robin L. [D-IL-2]
IL • D
Sponsored 3/5/2025
Rep. Steil, Bryan [R-WI-1]
WI • R
Sponsored 3/5/2025
Rep. Vindman, Eugene Simon [D-VA-7]
VA • D
Sponsored 3/25/2025
McDowell
NC • R
Sponsored 3/31/2025
Rep. Sorensen, Eric [D-IL-17]
IL • D
Sponsored 4/24/2025
Auchincloss
MA • D
Sponsored 5/29/2025
Van Drew
NJ • R
Sponsored 6/12/2025
Knott
NC • R
Sponsored 7/14/2025
Rep. Smith, Christopher H. [R-NJ-4]
NJ • R
Sponsored 7/17/2025
Thompson (CA)
CA • D
Sponsored 7/17/2025
Rep. Rouzer, David [R-NC-7]
NC • R
Sponsored 7/21/2025
Simpson
ID • R
Sponsored 7/21/2025
Rescom. Hernández, Pablo Jose [D-PR-At Large]
PR • D
Sponsored 7/21/2025
Rep. Tokuda, Jill N. [D-HI-2]
HI • D
Sponsored 7/23/2025
Rep. Grothman, Glenn [R-WI-6]
WI • R
Sponsored 7/29/2025
Gray
CA • D
Sponsored 7/29/2025
Bentz
OR • R
Sponsored 8/1/2025
Rep. Min, Dave [D-CA-47]
CA • D
Sponsored 8/12/2025
Rep. Carter, Earl L. "Buddy" [R-GA-1]
GA • R
Sponsored 8/15/2025
Rep. Letlow, Julia [R-LA-5]
LA • R
Sponsored 8/19/2025
Rep. Baird, James R. [R-IN-4]
IN • R
Sponsored 8/19/2025
Rep. Scholten, Hillary J. [D-MI-3]
MI • D
Sponsored 8/29/2025
Rep. Kim, Young [R-CA-40]
CA • R
Sponsored 9/2/2025
Van Duyne
TX • R
Sponsored 9/8/2025
Rep. Weber, Randy K. Sr. [R-TX-14]
TX • R
Sponsored 9/9/2025
Rep. Nunn, Zachary [R-IA-3]
IA • R
Sponsored 9/9/2025
Rep. McDonald Rivet, Kristen [D-MI-8]
MI • D
Sponsored 9/9/2025
Nehls
TX • R
Sponsored 9/9/2025
Rep. Van Orden, Derrick [R-WI-3]
WI • R
Sponsored 9/9/2025
Budzinski
IL • D
Sponsored 9/10/2025
McBride
DE • D
Sponsored 9/11/2025
Lucas
OK • R
Sponsored 9/15/2025
Rep. Jackson, Ronny [R-TX-13]
TX • R
Sponsored 9/19/2025
Rep. Fischbach, Michelle [R-MN-7]
MN • R
Sponsored 9/26/2025
Kennedy (NY)
NY • D
Sponsored 9/30/2025
Evans (CO)
CO • R
Sponsored 10/17/2025
Schrier
WA • D
Sponsored 10/17/2025
Schmidt
KS • R
Sponsored 10/17/2025
Lofgren
CA • D
Sponsored 12/4/2025
Riley (NY)
NY • D
Sponsored 12/9/2025
Rep. Garamendi, John [D-CA-8]
CA • D
Sponsored 12/17/2025
Rep. Vasquez, Gabe [D-NM-2]
NM • D
Sponsored 1/6/2026
Rep. Perez, Marie Gluesenkamp [D-WA-3]
WA • D
Sponsored 1/7/2026
DesJarlais
TN • R
Sponsored 2/9/2026
Ivey
MD • D
Sponsored 2/11/2026
Rep. Bergman, Jack [R-MI-1]
MI • R
Sponsored 2/24/2026
Rep. Foushee, Valerie P. [D-NC-4]
NC • D
Sponsored 2/26/2026
Rep. Alford, Mark [R-MO-4]
MO • R
Sponsored 3/3/2026
Langworthy
NY • R
Sponsored 3/20/2026
Trahan
MA • D
Sponsored 3/26/2026
Moore (NC)
NC • R
Sponsored 3/30/2026
Rep. Gottheimer, Josh [D-NJ-5]
NJ • D
Sponsored 4/6/2026
Edwards
NC • R
Sponsored 4/16/2026
Rep. Gillen, Laura [D-NY-4]
NY • D
Sponsored 4/27/2026
Rep. Mackenzie, Ryan [R-PA-7]
PA • R
Sponsored 5/11/2026
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov